Vanda
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (67)
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Started: 3/27/2026
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
Started: 9/22/2025
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Started: 3/3/2025
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Started: 2/17/2026
Randomized Withdrawal Study in Patients With Schizophrenia
Started: 5/14/2025
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Started: 12/9/2020
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Started: 4/21/2025
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
Started: 1/9/2024
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
Started: 10/8/2024
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Started: 2/27/2023
Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP
Started: 4/21/2022
Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP
Started: 4/14/2022
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
Started: 8/20/2019
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
Started: 9/9/2023
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Started: 11/15/2021
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
Started: 10/21/2019
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)
Started: 7/9/2018
Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
Started: 3/22/2021
Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
Started: 10/16/2017
Relapse Prevention Study in Patients With Schizophrenia
Started: 2/1/2011
ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection
Started: 4/13/2020
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Started: 10/1/2011
Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
Started: 8/1/2010
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Started: 9/1/2011
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Started: 9/15/2025
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Started: 10/1/2025
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
Started: 5/5/2025
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
Started: 2/25/2025
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris
Started: 5/15/2021
A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
Started: 5/4/2021
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa
Started: 7/7/2021
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis
Started: 1/25/2021
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis
Started: 1/30/2019
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis
Started: 5/20/2019
Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies
Started: 11/21/2020
Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Started: 12/20/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Started: 11/1/2016
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Started: 1/19/2016
Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
Started: 12/10/2013
A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
Started: 6/1/2022
Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
Started: 2/23/2021
Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS
Started: 9/1/2015
A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
Started: 7/1/2016
Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
Started: 9/1/2011
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Started: 9/27/2018
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
Started: 5/13/2025
Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions
Started: 7/11/2024
Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers
Started: 2/1/2021
Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects
Started: 7/19/2018
Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
Started: 10/4/2016
Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers
Started: 5/18/2022
A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
Started: 1/13/2021
Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers
Started: 6/30/2021
Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
Started: 10/7/2019
Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
Started: 10/1/2011
Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects
Started: 11/1/2015
Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P
Started: 8/1/2013
Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
Started: 1/1/2011
A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects
Started: 8/1/2011
Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function
Started: 2/1/2012
Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine
Started: 2/1/2012
Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.
Started: 6/1/2012
Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol
Started: 4/1/2012
Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects
Started: 11/1/2011
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Started: 5/24/2023
Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
Started: 5/1/2014